Oct 15, 2026
Check out the latest UK Price Watch article in the Generics Bulletin for analysis and insight on September 2026 product launches, the biggest risers, the biggest fallers and the fastest movers…. with market data provided by WaveData. Dave Wallace, editor at Generics...
Sep 17, 2026
The creation a Single National Formulary (SNF) for England was back as the agenda at the Healthcare Distribution Association (HDA UK) Supply Chain Resilience Group which Charles Joynson, WaveData MD, attended last week. NHS England is now actively moving toward an SNF...
Jun 30, 2026
The graph shows the average PI price for a group of respiratory products. Each of the branded products shown in the chart is heavily effected by parallel imports as they were the most commonly traded PI respiratory products in May 2026, and in the top 12 of all...
Mar 5, 2026
There has been a lot of discussion about Category H at recent events, online and on socials. Charles Joynson, WaveData MD, poses the question; ‘Will it cut another group of generics to the bone and seriously damage pharmacy and supplier profitability? Or will it...
Feb 13, 2026
Charles Joynson, WaveData MD, was delighted to join Jeremy Durrant, Director of Communications and External Engagement at Medicines UK, in the latest episode of their podcast Medicine Matters. It’s a lively discussion, looking at pricing trends over the last 12...
Sep 16, 2025
Leslie Galloway, EMIG Chairman, shared his analysis of VPAG. Here’s Charles’ key takeaways: · The NHS VPAG rebate is £1bn over 3 years and so is a fixed rebate with risk share. · Global Pharma CEOs have asked for lower rebates and a better deal, that...
